Literature DB >> 2395330

Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis.

J A Bruijn1, E H van Leer, H J Baelde, W E Corver, P C Hogendoorn, G J Fleuren.   

Abstract

The present studies dealt with the pathogenesis of renal involvement in murine chronic graft-versus-host disease, which is a model for human systemic lupus erythematosus. The disease was induced in (C57BL10xDBA/2)F1 hybrids by injection of DBA/2 lymphocytes. The animals developed systemic disease accompanied by deposition of autoantibodies in the glomeruli and a lupus type of nephritis. Antibodies were eluted from glomeruli isolated during various stages of the disease by magnetic extraction from iron-perfused kidneys. For assessment of the specificity of the antibodies, we used indirect immunofluorescence, an enzyme-linked immunosorbent assay, and immunoblotting. In glomeruli from week 4, autoantibodies were found to be directed against several antigens, among which were the glomerular basement membrane component laminin and the glomerular enzyme dipeptidyl peptidase IV, whereas week 8 glomeruli also showed antibodies directed against nuclear antigens. Both laminin and dipeptidyl peptidase IV are known nephritogenic antigens occurring in renal tubular epithelial brush border preparations. Antibodies eluted from isolated glomeruli of diseased animals bound in a granular pattern along the glomerular capillary wall after in vivo transfer. Anti-renal tubular epithelial antibodies in the sera of diseased animals were affinity purified and injected into naive mice, which induced immune complex glomerulonephritis and proteinuria, thus confirming the nephritogenic role of these autoantibodies in this model.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395330

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

Review 1.  Autoimmunity and glomerulonephritis.

Authors:  R Saxena; C Johansson; P Bygren; J Wieslander
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.

Authors:  Quan-Zhen Li; Quan Li Zhen; Chun Xie; Tianfu Wu; Meggan Mackay; Cynthia Aranow; Chaim Putterman; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection.

Authors:  M Sutmuller; J J Baelde; M P Madaio; J A Bruijn; E De Heer
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  Heymann nephritis revisited--new insights into the pathogenesis of experimental membranous glomerulonephritis.

Authors:  E De Heer; J A Bruijn; P J Hoedemaeker
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Selective Memory to Apoptotic Cell-Derived Self-Antigens with Implications for Systemic Lupus Erythematosus Development.

Authors:  Amanda Duhlin; Yunying Chen; Fredrik Wermeling; Saikiran K Sedimbi; Emma Lindh; Rahul Shinde; Marie Jo Halaby; Ylva Kaiser; Ola Winqvist; Tracy L McGaha; Mikael C I Karlsson
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

Review 6.  Glomerular antibodies in lupus nephritis.

Authors:  Catherine Hanrotel-Saliou; Isabelle Segalen; Yannick Le Meur; Pierre Youinou; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

7.  Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.

Authors:  E H Van Leer; P Ronco; P Verroust; A M van der Wal; P J Hoedemaeker; E De Heer
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Qualitative alterations in laminin expression in experimental lupus nephritis.

Authors:  C J Kootstra; E C Bergijk; A Veninga; F A Prins; E de Heer; D R Abrahamson; J A Bruijn
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

9.  Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.

Authors:  R Saxena; G Sturfelt; O Nived; J Wieslander
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

10.  Gender-related influences on the development of chronic graft-versus-host disease-induced experimental lupus nephritis.

Authors:  R A Treurniet; E C Bergijk; J J Baelde; E De Heer; P J Hoedemaeker; J A Bruijn
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.